The transaction includes the sales and delivery of lactic acid and lactic acid based derivatives in India, though now production facilities will be acquired. Production will remain with Malladi Drugs and Pharmaceuticals Limited (MDPL) which will produce derivatives on behalf of Corbion Purac.
"For over 80 years Corbion Purac has been an established name and superior service provider in the food and pharmaceutical industry with lactic acid and its derivatives. MSL has a very strong customer base and distribution network in India. This acquisition will enable Corbion to grow its distribution network and customer service in India even further," said Frank Goovaerts, regional vice president of Corbion Purac Asia Pacific.